Press Release: CMG and Oxaliplatin studies for colon cancer
Jul 26, 2021
Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin in an Animal Study for Colon Cancer.
Comments